News & Perspective

Dec 26, 2012

Dec 26, 2012

Experts differ on HHS select-agent proposal for H5N1

(CIDRAP News) – Some professional groups and scientists think it's a good idea to classify highly pathogenic avian (HPAI) H5N1 influenza viruses as "select agents" requiring special research precautions, while others say the step is unnecessary and would impede research, according to comments they have filed with the US Department of Health and Human Services (HHS).

Dec 17, 2012

Dec 17, 2012

H5N1 researchers question proposed HHS funding framework

(CIDRAP News) – Federal health officials are in the midst of crafting a framework for funding H5N1 avian influenza gain-of-function studies, and today at a workshop they heard varied feedback from researchers, biosecurity experts, and others.

Dec 17, 2012

Dec 17, 2012

With more surveillance, flu patterns in Africa begin to emerge

(CIDRAP News) – Increased surveillance in recent years has begun to fill in some of the huge information gaps regarding influenza in Africa, which should eventually make it possible to develop or improve public health interventions, according to a big collection of articles published recently in the Journal of Infectious Diseases (JID).

Oct 30, 2012

Oct 30, 2012

CDC profiles wide range of global flu activities

(CIDRAP News) – An annual report released yesterday by the US Centers for Disease Control and Prevention (CDC) profiles a wide range of CDC influenza-related projects around the world, from flu surveillance in Indonesia to vaccine effectiveness studies in El Salvador and epidemiology training in Ghana.

Oct 18, 2012

Oct 18, 2012

HHS seeks comments on risks of H5N1 research

(CIDRAP News) – Federal health officials are inviting the public to weigh in on whether research on H5N1 avian influenza viruses, including strains modified in the lab to make them more transmissible, is risky enough to require new safety regulations and precautions.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»